Ivory Graft Ltd.

Ivory Graft Ltd. has developed a naturally sourced, bioresorbable dentin graft material for the repair and augmentation of bone defects. Privately held, the company was founded and is funded by leading clinicians and industry leaders. Located in central Israel, Ivory Graft benefits from the country's innovative medical startup ecosystem. Ivory Dentin Graft™ - The First and Only Dentin Graft The Ivory Dentin Graft™ was developed based upon years of scientific research and peer-reviewed publications on the advantages of autologous dentin grafts. Dentin's composition is very similar to bone, due to its high mineral phase and its tubular architecture. Dentin is considered an excellent bone graft substitute grafting material. Ivory Dentin Graft is an active organic matrix. It retains the natural form of the sourced porcine dentin as well as the protein matrix consisting largely of collagen, and has been adapted for use in dental procedures. For the best results and ideal hard tissue generation, physicomechanical properties of the graft should match that of the host bone, in addition to biological connectivity and bio-active organic matrix. Ivory Dentin Graft promotes new bone formation as well as promoting good integration between the host-bone and graft material. These two features are important for tissue regeneration and integration during early bone remodeling processes that follow tooth extraction and grafting, and facilitate osteogenic activity to promote successful subsequent implant placement. CE Marked (MDR 2017/745), Ivory Dentin Graft™ is a graft substitute, naturally sourced from porcine dentin, obtained by standardized and controlled manufacturing procedures. This unique dentin graft is safe and effective, has no additives, and carries no BSE risk. In the USA, Ivory Dentin Graft™ is not yet available for commercial use .

• Employees 5
• Founded 2013